Serum free light chains and multiple myeloma: Is it time to extend their application?-Reference-Cited by-同舟云学术

Serum free light chains and multiple myeloma: Is it time to extend their application?

Published:2020-04 Issue:4 Volume:8 Page:617-624
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Markovic Uros¹^ORCID,Leotta Valerio¹,Tibullo Daniele²,Giubbolini Rachele¹³,Romano Alessandra¹,Del Fabro Vittorio¹,Parrinello Nunziatina Laura¹,Cannizzaro Maria Teresa⁴,Di Raimondo Francesco¹,Conticello Concetta¹

Affiliation:

1. UOC di Ematologia con Trapianto di Midollo Osseo AOU "Policlinico‐Vittorio Emanuele” Catania Italy

2. Department of Biomedical and Biotechnological Sciences University of Catania Catania Italy

3. Division of Hematology Largo del Pozzo AOU Policlinico Modena Italy

4. Radiology via Santa Sofia 78 AOU Policlinico‐"Vittorio Emanuele" Catania Italy

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.2636

Reference25 articles.

1. Plasma Cell Disorders

2. Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

3. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

4. Measurement of free light chains – pros and cons of current methods

5. Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural modification of 2‐phenylquinoline‐4‐carboxylic acid containing SIRT3 inhibitors for the cancer differentiation therapy;Chemical Biology & Drug Design;2024-07-31

2. Investigation of the Diagnostic Value of sFLC and Other Indicators in the Detection of M Protein in LCMM;Clinical Laboratory;2023

3. Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study;Biomedicines;2022-07-10

4. Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study;Cancers;2021-11-29

5. Involved free light chain: an early independent predictor of response and progression in multiple myeloma;Leukemia & Lymphoma;2021-04-02